Johnson & Johnson

$144.48

+0.61 (+0.01%) Today
1 Day1D

5 Days5D

1 Month1M

6 Months6M

YTDYTD

1 Year1Y

2 Years2Y

5 Years5Y

MaxMax

About

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

CEO

Alex Gorsky

Employees

132200

Headquarters

One Johnson & Johnson Plaza New Brunswick, NJ, 08933

Founded

1886

Market Cap

Johnson & Johnson News

How COVID-19 has affected Big Pharma and biotech Nov 23, 2020

Biotechnology traces its roots to the Neolithic era when early civilizations discovered how to ferment grains to prepare alcoholic brews and bread. It wasn’t until genetic engineering became mainstream in the mid-1970s, however, that biotechnology, as we know it today, was launched. The field continues to evolve today. The advent of new technology has revolutionized the market…

MedTech 100 roundup: Industry remains strong despite slight dip Nov 23, 2020

The heights of two weeks ago may not have been reached, but the medtech industry — despite a slight dip — performed well in the stock markets once again. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.99 (Nov. 20), marking a 1% downturn […]

The top 5 MassDevice stories of the week — November 20, 2020 Nov 20, 2020

The past week saw major news in the robotic surgery space, with Johnson & Johnson (NYSE:JNJ) unveiling its new Ottava platform. Want to hear more about the week’s top medtech news on MassDevice? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” — as well as fictional monsters that come out of […]

BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system Nov 19, 2020

Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform…

BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system Nov 19, 2020

Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform […]